Deficient Mismatch Repair Represents a Distinct Molecular Feature of Early-Onset Colorectal Cancer in Chinese Single-Center Cohort

IF 4.9 2区 医学 Q1 ONCOLOGY
International Journal of Cancer Pub Date : 2026-09-22 Epub Date: 2026-07-31 DOI:10.1002/ijc.70667
Deng Tang, Zhigang Mao, Siqi Lan, Yali Song, Si Chen, Yuemei Chen, Mi Su, Yufei Tang, Chengyi Zhu, Ruiting Yan, Ji Zhang, Yufang Wang
{"title":"Deficient Mismatch Repair Represents a Distinct Molecular Feature of Early-Onset Colorectal Cancer in Chinese Single-Center Cohort","authors":"Deng Tang,&nbsp;Zhigang Mao,&nbsp;Siqi Lan,&nbsp;Yali Song,&nbsp;Si Chen,&nbsp;Yuemei Chen,&nbsp;Mi Su,&nbsp;Yufei Tang,&nbsp;Chengyi Zhu,&nbsp;Ruiting Yan,&nbsp;Ji Zhang,&nbsp;Yufang Wang","doi":"10.1002/ijc.70667","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Early-onset colorectal cancer (EOCRC), defined as colorectal cancer diagnosed before the age of 50 years, is increasing worldwide, with a similar trend emerging in China. However, the clinicopathological and mismatch repair features of EOCRC in Chinese patients remain insufficiently characterized. We retrospectively reviewed 23,414 colorectal neoplasia cases diagnosed at West China Hospital between November 2008 and June 2023. Among these, 4,159 colorectal cancer cases with complete immunohistochemical assessment of MLH1, PMS2, MSH2, and MSH6 were included in the primary analysis. Clinicopathological characteristics and mismatch repair status were compared between EOCRC and late-onset colorectal cancer (LOCRC), with additional stratification by documented family history. Multivariable logistic regression was used to evaluate the independent association between early-onset status and deficient mismatch repair (dMMR). Compared with LOCRC, EOCRC showed less favorable clinicopathological features, including higher proportions of poor differentiation, T4 tumors, nodal involvement, and advanced TNM stage. EOCRC also had a significantly higher prevalence of dMMR. In multivariable analysis, early-onset status was independently associated with dMMR in the overall cohort (adjusted OR, 2.27; 95% CI, 1.60–3.22; <i>p</i> &lt; 0.001), and among patients without documented family history (adjusted OR, 1.95; 95% CI, 1.33–2.86; <i>p</i> &lt; 0.001). Patterns of MMR protein loss differed according to documented family history status. In conclusion, EOCRC in this Chinese MMR-tested cohort was associated with more advanced clinicopathological features and a higher prevalence of dMMR, supporting routine MMR assessment in young patients with colorectal cancer.</p>\n </div>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":"159 10","pages":"2473-2484"},"PeriodicalIF":4.9000,"publicationDate":"2026-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ijc.70667","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/31 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Early-onset colorectal cancer (EOCRC), defined as colorectal cancer diagnosed before the age of 50 years, is increasing worldwide, with a similar trend emerging in China. However, the clinicopathological and mismatch repair features of EOCRC in Chinese patients remain insufficiently characterized. We retrospectively reviewed 23,414 colorectal neoplasia cases diagnosed at West China Hospital between November 2008 and June 2023. Among these, 4,159 colorectal cancer cases with complete immunohistochemical assessment of MLH1, PMS2, MSH2, and MSH6 were included in the primary analysis. Clinicopathological characteristics and mismatch repair status were compared between EOCRC and late-onset colorectal cancer (LOCRC), with additional stratification by documented family history. Multivariable logistic regression was used to evaluate the independent association between early-onset status and deficient mismatch repair (dMMR). Compared with LOCRC, EOCRC showed less favorable clinicopathological features, including higher proportions of poor differentiation, T4 tumors, nodal involvement, and advanced TNM stage. EOCRC also had a significantly higher prevalence of dMMR. In multivariable analysis, early-onset status was independently associated with dMMR in the overall cohort (adjusted OR, 2.27; 95% CI, 1.60–3.22; p < 0.001), and among patients without documented family history (adjusted OR, 1.95; 95% CI, 1.33–2.86; p < 0.001). Patterns of MMR protein loss differed according to documented family history status. In conclusion, EOCRC in this Chinese MMR-tested cohort was associated with more advanced clinicopathological features and a higher prevalence of dMMR, supporting routine MMR assessment in young patients with colorectal cancer.

缺陷错配修复在中国单中心队列中代表了早发性结直肠癌的独特分子特征。
早发性结直肠癌(EOCRC),定义为50岁前诊断的结直肠癌,在全球范围内正在增加,中国也出现了类似的趋势。然而,中国患者EOCRC的临床病理和错配修复特征仍然不够明确。我们回顾性分析了2008年11月至2023年6月在华西医院诊断的23,414例结直肠肿瘤病例。其中,4159例结肠直肠癌患者进行了完整的MLH1、PMS2、MSH2和MSH6免疫组化评估,纳入初步分析。比较了EOCRC和晚发性结直肠癌(LOCRC)的临床病理特征和错配修复状态,并通过记录的家族史进行了额外的分层。采用多变量logistic回归评估早发状态与缺陷错配修复(dMMR)之间的独立关联。与LOCRC相比,EOCRC表现出较差的临床病理特征,包括低分化、T4肿瘤、淋巴结受累和TNM晚期的比例更高。EOCRC的dMMR患病率也明显较高。在多变量分析中,在整个队列中,早发状态与dMMR独立相关(调整后的OR为2.27;95% CI为1.60-3.22
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
13.40
自引率
3.10%
发文量
460
审稿时长
2 months
期刊介绍: The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control—UICC; it appears twice a month. IJC invites submission of manuscripts under a broad scope of topics relevant to experimental and clinical cancer research and publishes original Research Articles and Short Reports under the following categories: -Cancer Epidemiology- Cancer Genetics and Epigenetics- Infectious Causes of Cancer- Innovative Tools and Methods- Molecular Cancer Biology- Tumor Immunology and Microenvironment- Tumor Markers and Signatures- Cancer Therapy and Prevention
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书